Piouka A, Farmakiotis D, Katsikis I, Macut D, Gerou S, Panidis D. Anti-Müllerian hormone levels reflect severity of PCOS but are negatively influenced by obesity: relationship with increased luteinizing hormone levels. Am J Physiol Endocrinol Metab 296: E238 -E243, 2009. First published October 28, 2008 doi:10.1152/ajpendo.90684.2008The objective of the study was the comparison of anti-Müllerian hormone (AMH) levels among obese or overweight and normalweight women with the four different polycystic ovary syndrome (PCOS) phenotypes and healthy control subjects. AMH levels were evaluated in four age-and body mass index (BMI)-matched groups of 25 normal-weight and 25 obese or overweight women each, belonging to the four main subsets of the syndrome resulting from combinations of the three diagnostic criteria [group 1: oligo-and/or anovulation (ANOV), hyperandrogenemia (HA), and polycystic ovaries (PCO) on ultrasonographic evaluation; group 2: ANOV and HA; group 3: HA and PCO, group 4: ANOV and PCO], and in 50 (25 obese or overweight and 25 normal weight) age-and BMI-matched healthy control subjects. Age, BMI, waist circumference, FSH, LH, prolactin, testosterone, ⌬4-androstenedione, dehydroepiandrosterone-sulfate, 17␣-OH-progesterone, fasting insulin, glucose, AMH, free androgen index, and homeostasis model assessment for insulin resistance index were analyzed. AMH levels were significantly higher in PCOS groups 1 and 2 compared with groups 3 and 4 and the control group and higher in PCOS groups 3 and 4 compared with the control group. AMH levels were significantly increased in normal-weight compared with obese and overweight women. AMH concentrations were independently predicted, in order of significance, by LH and testosterone levels, BMI (negatively), and the total number of follicles 2-9 mm in diameter. The differences in circulating AMH levels between the main phenotypic groups of PCOS women appear to reflect the severity of the syndrome, but are negatively affected by obesity. Increased LH levels might be the most significant independent link between PCOS-associated disorders of ovulation and the observed increase in circulating AMH concentration.
arise, according to the combination of its main three manifestations (Table 1) .
Despite the recommended criteria, there is still controversy among the experts about the importance of each feature and the severity of the reproductive and metabolic dysfunction every phenotype implies (4, 18) . Thus the phenotypic group with all three criteria is termed "severe" (18) , while, notably, the presence of both ANOV and HA, independent of PCO, was required for the diagnosis of the syndrome before 2003 (30) .
Obesity is present in varying degrees (30 -70%) in women with PCOS (1) and is usually of the central type (14) . Central obesity, being a prominent feature of the so-called metabolic syndrome, is directly linked to increased peripheral insulin resistance (IR) (2) . Furthermore, PCOS itself has been shown to confer a risk for IR, beyond that caused by obesity alone (5) .
ANOV in PCOS is apparently due to a twofold disorder of follicular development: first, early follicular growth is excessive; second, the selection of one follicle from the increased pool and its further maturation to a dominant follicle do not occur (follicular arrest) (11) . Anti-Müllerian hormone (AMH) is a member of the transforming growth factor-␤ (TGF-␤) superfamily of glycoproteins that has been found to play an important role in both of the above processes by 1) inhibiting the initial recruitment of primordial follicles (7, 13) and 2) promoting follicular arrest (8, 13) . Indeed, AMH levels have been found to be increased in both serum (23) (24) (25) and follicular fluid (22) of women with PCOS, while its expression is, paradoxically, reduced during the initial stage of follicular recruitment in anovulatory women with PCO (26) . The relationship between AMH and obesity or IR in PCOS has not been studied so far.
In light of the above evidence, the present study was designed to 1) explore the hypothesis that the severity of PCOS is reflected upon AMH levels and 2) assess the possible correlations between AMH, obesity, and the hormonal or metabolic parameters of the syndrome. To our knowledge, this is the first study to classify the PCOS population in four equally sized groups, matched for body mass index (BMI) and age, according to PCOS phenotype. (27, 28 ) (see Study protocol). None of the women studied had galactorrhea or any endocrine or systemic disease that could possibly affect reproductive physiology. A Synacthen test was performed with tetracosactide (Synacthen 0.25 mg/1 ml; Novartis Pharma, RueilMalmaison, France) on each woman with a basal 17-OH-progesterone (17-OH-P) plasma level Ͼ1.5 ng/ml to exclude congenital adrenal hyperplasia.
METHODS

Subjects
No woman reported use of any medication that could interfere with the normal function of the hypothalamic-pituitary-gonadal axis during the last semester. Informed consent was obtained from all women, and the study was approved by the Institutional Review Board; the study met the requirements of the 1975 Helsinki guidelines.
Study protocol. In all women, weight, height, and waist circumference (W) were measured. Body weight was measured with analog scales and in light clothing; height was measured barefoot with a stadiometer. BMI (kg/m 2 ) was calculated by dividing weight by height squared to assess obesity. W was obtained as the smallest circumference at the level of the umbilicus.
Baseline blood samples were collected between days 3 and 7 of the menstrual cycle in the control group and after a spontaneous bleeding episode in the PCOS group, after an overnight fast. The circulating levels of follicle-stimulating hormone (FSH), luteinizing hormone (LH), prolactin (PRL), total testosterone (T), ⌬ 4-androstenedione (⌬ 4A), dehydroepiandrosterone-sulfate (DHEA-S), 17-OH-P, sex hormone-binding globulin (SHBG), glucose, insulin, and AMH were measured.
Women with PCOS were classified into the following four groups, according to their clinical, biochemical, and sonographic characteristics (Table 1) .
Group 1 included 50 (25 normal weight and 25 obese and overweight) women presenting with oligo-or amenorrhea (Ͻ8 spontaneous hemorrhagic episodes/yr), HA (early follicular phase T Ͼ 60 ng/dl, corresponding to the mean ϩ 2 SD of 100 control subjects, measured in our lab), and PCO by sonographic evaluation (Ն12 small follicles in at least 1 ovary and/or ovarian volume Ͼ10 cm 3 ) ("severe" PCOS).
Group 2 included 50 (25 normal weight and 25 obese and overweight) women presenting with oligo-or amenorrhea and HA without PCO.
Group 3 included 50 (25 normal weight and 25 obese and overweight) women presenting with HA and PCO, without oligo-or amenorrhea ("ovulatory" PCOS).
Group 4 included 50 (25 normal weight and 25 obese and overweight) women presenting with oligo-or amenorrhea and PCO, without HA ("mild" PCOS).
All women were selected from a large cohort of outpatients at our department (4), in order for the above groups to be matched for age and BMI (Tables 2 and 3) .
Assay methods and calculations. Plasma glucose, insulin, LH, FSH, PRL, androgen, and 17-OH-P concentrations were measured as previously described (4). AMH concentrations were measured with an enzymatically amplified two-sided immunoassay [DSL-10-14400 Active Müllerian Inhibiting Substance/AMH enzyme-linked immunosorbent assay (ELISA) kit, DSL Laboratories, Webster, TX]. The theoretical sensitivity of the method is 0.006 ng/ml, the intra-assay coefficient of variation for high values is 3.3%, and the interassay coefficient of variation for high values is 6.7%.
The free androgen index (FAI) was calculated as T (nmol/l) ϫ 100/SHBG (nmol/l) (17) . The homeostasis model assessment for insulin resistance index (HOMA-IR) was calculated according to the following formula: fasting insulin (IU/ml) ϫ fasting glucose (mmol/l)/ 22.5 (16) .
Ultrasound evaluation. Transvaginal ultrasound scans of the ovaries were performed by an experienced sonographer (I. Katsikis) in women who participated in the study. Ovarian volume was calculated by the formula V ϭ (/6) ϫ D length ϫ Dwidth ϫ Dthickness, where D is dimension. The presence of PCO was diagnosed by the presence of 12 or more follicles in each ovary measuring 2-9 mm in diameter and/or increased ovarian volume (Ͼ10 cm 3 ). Statistical analysis. Normality of distribution was assessed with the one-sample Kolmogorov-Smirnoff test, and values that were not normally distributed were log-transformed. To avoid type I error, comparisons of means were performed with general linear model (GLM)-based two-way analysis of variance (ANOVA) with post hoc analysis for pairwise comparisons after Bonferroni adjustment.
Correlations were assessed with calculation of the Spearman coefficient. Independent relationships were assessed by means of multiple regression analysis after log transformation. Two-tailed statistical significance was set at 5%. Statistical analyses were performed with SPSS software v. 15.0 (SPSS, Chicago, IL). The graph in Fig. 1 was designed with MedCalc software (v. 8.0.0.1, www.medcalc.be).
RESULTS
Effects of PCOS.
The women of the five groups did not differ significantly in age, BMI, W, and PRL levels. FSH levels were borderline lower in women with PCOS (F ϭ 2.5, P ϭ 0.04), specifically those of group 4, compared with control subjects (P ϭ 0.03). LH levels were higher in women with PCOS (F ϭ 5.5, P Ͻ 0.001); in pairwise comparisons, women of group 1 had significantly higher LH levels compared with women of group 3 (P ϭ 0.002) and control subjects (P ϭ 0.001) ( Tables 2 and 3) .
By definition, T (F ϭ 68.2), ⌬ 4 A (F ϭ 35.9), and DHEA-S (F ϭ 13.0) levels, as well as FAI values (F ϭ 52.0), were significantly higher in women with HA (PCOS groups 1-3), compared with those without (PCOS group 4 and control subjects) (P Ͻ 0.001 in all comparisons), whereas no difference was observed between the former three groups. No difference in T and DHEA-S levels was observed between the latter two groups (group 4 and control subjects), whereas ⌬ 4 A levels and FAI values were higher in women of group 4 compared with control subjects (P ϭ 0.003 and 0.028, respectively). 17-OH-P levels were higher in all women with PCOS compared with control subjects (F ϭ 6.7, P Ͻ 0.001; P ϭ 0.005 for group 1, P ϭ 0.009 for group 2, P Ͻ 0.001 for group 3, and P ϭ 0.02 for group 4), but no significant differences were observed between the four groups of women with the syndrome (Tables 2 and 3 ).
The total number of follicles 2-9 mm on ultrasonography (F ϭ 57.60) as well as the mean ovarian volume (F ϭ 8.24) were by definition higher in women with PCO (PCOS groups 1, 3, and 4), compared with those without (group 2 and control subjects, P Ͻ 0.001 in all comparisons). No difference was observed between the former three or the latter two groups. (Tables 2 and 3) .
SHBG levels were significantly higher in control subjects compared with all HA groups of women with PCOS (groups 1-3; F ϭ 9.4, P Ͻ 0.001 in all comparisons) and in women of group 4 (non-HA PCOS) compared with group 2 (P ϭ 0.021) ( Tables 2 and 3) . No statistical significance was observed between women of the five groups in indexes of IR (fasting insulin levels and HOMA-IR levels), although a trend for higher HOMA-IR values was observed in women with PCOS (Tables 2 and 3 ; F ϭ 2.0, P ϭ 0.093).
The concentrations of AMH (F ϭ 40.4, P Ͻ 0.001) were significantly higher in groups 1 and 2 compared with all other groups of women with PCOS and the control group (P Ͻ 0.001 in all comparisons, except for group 2 vs. groups 3 and 4, P ϭ 0.002 and 0.001, respectively). AMH levels were significantly higher in women with PCOS of groups 3 and 4 compared with the control group (P ϭ 0.008 and 0.025, respectively) ( Fig. 1 , Tables 2 and 3) . Effects of obesity. Obese and overweight women had significantly higher levels of fasting insulin (F ϭ 86.3), HOMA-IR (F ϭ 91.1), and FAI values (F ϭ 40.1) compared with normal-weight women (Tables 2 and 3 , P Ͻ 0.001 in all comparisons). LH, SHBG, and AMH levels were significantly lower in obese and overweight women compared with normalweight women (F ϭ 7.9, P ϭ 0.005; F ϭ 44.8, P Ͻ 0.001; F ϭ 64.7, P Ͻ 0.001, respectively). No significant interactions were observed (Tables 2 and 3, Fig. 1) .
AMH determinants. AMH levels were negatively correlated with age (r ϭ Ϫ0.215, P ϭ 0.001), BMI (r ϭ Ϫ0.310, P Ͻ 0.001), and W (r ϭ Ϫ0.263, P Ͻ 0.001) and positively with LH (r ϭ ϩ0.374, P Ͻ 0.001), T (r ϭ ϩ0.444, P Ͻ 0.001), ⌬ 4 A (r ϭ ϩ0.398, P Ͻ 0.001), 17-OH-P (r ϭ 0.186, P ϭ0.003), FAI values (r ϭ ϩ0.219, P ϭ 0.001), total number of small follicles (r ϭ 0.263, P Ͻ 0.001), and mean ovarian volume (r ϭ 0.178, P ϭ 0.007).
Using multiple regression analysis on all of the above parameters, four models predicted serum AMH concentrations. In model 1, LH concentration was the only significant determinant. In model 2, T was added. In model 3 BMI and in model 4 LH and T levels, BMI, and total number of follicles 2-9 mm were the significant independent determinants (Table 4) .
DISCUSSION
The present study confirmed previous results (23-25) on increased serum AMH levels in women with PCOS compared with healthy control subjects (Tables 2 and 3, Fig. 1 ). Ovulatory disorders in women with the syndrome are caused by 1) an increased early follicular growth, resulting in a larger than normal reserve of selectable follicles, and 2) defective selection of one follicle from this increased pool, leading to follicular arrest (11) . Since AMH has been shown to inhibit the initial follicle recruitment (7), but also to cause follicular arrest (8) , and AMH levels are increased in the syndrome, it has been proposed that its involvement in PCOS-associated ANOV lies only in the second mechanism (11) . Nevertheless, more recent data support an additional PCOS-associated defect in the early production of AMH by the granulosa cells (GC) of growing follicles, indicating a possible involvement of decreased AMH in the disordered early follicle development observed in anovulatory women with the syndrome (26) .
It has also been reported that the excess in AMH production by PCO is a result of the increased small follicle number per se (11) . However, as indicated by the present results, the increased number of follicles 2-9 mm in diameter, demonstrated as PCO sonographic morphology, is not the only determinant of serum AMH. Indeed, AMH levels were higher in anovulatory and hyperandrogenic women with NIH-defined "classical" PCOS, without PCO morphology (group 2), compared with both ovulatory women with PCO and HA (group 3) and anovulatory women with PCO but normal androgen levels (group 4) (Tables 2 and 3, Fig. 1 ). Therefore, AMH levels reflect the severity of PCOS, traditionally defined by its two cardinal elements, i.e., ANOV and HA (30) .
Moreover, the total number of 2-to 9-mm follicles, although an independent determinant, contributed only an additional 5.3% to the variance of AMH levels, as opposed to 18% by LH levels alone and an additional 9.5% by circulating T (Table 4) . Notably, cells from normal ovaries have been found to produce very little response to LH, whereas this gonadotropin stimulated AMH production fourfold in cells from PCO (22) . Furthermore, a significant and independent positive association between LH and AMH levels has been observed recently in women with clomiphene-resistant PCOS undergoing low-dose FSH treatment of anovulation (12) . These findings support our own observation that serum AMH concentration was positively influenced by LH levels (Table 4) . After all, LH levels were markedly high in women with "severe" PCOS (group 1), who also had the highest AMH concentrations (Fig. 1, Tables 2 and 3 ).
The strong independent positive effect of LH on GC production of AMH was also demonstrated in the consistently higher AMH levels in normal-weight women, who have been shown to have higher LH levels compared with obese and overweight women both in the present (Tables 2 and 3) and previous (15, 19, 20, 25) studies. Although in a previous report on adolescent girls with the syndrome (25) no significant association between AMH levels and BMI was observed, our results are in agreement with another recent study in the adult population, in which AMH levels were 65% lower in obese women compared with normal-weight women of late reproductive age (9) . To sum up, a strong positive association between LH and AMH levels was demonstrated in the present study by 1) the strong independent correlation between the two hormones, explaining the most significant proportion of AMH variance (Table 4) ; 2) the significantly higher LH concentrations in women with "severe" PCOS (group 1) (Fig. 1, Tables 2 and 3) , along with the highest levels of serum AMH; and 3) most importantly, the substantially lower AMH levels in obese and overweight compared with normal-weight women, which could not possibly be accounted for by any of the other PCOS-associated hormonal or metabolic defects (Fig. 1 , Tables 2 and 3).
It should be noted that an earlier LH receptor gain in anovulatory patients with PCOS has been proposed (10, 11, 29) . Therefore, premature LH action on the GC of anovulatory women with the syndrome might offer an additional contribution to the follicular arrest, being the link between PCOSassociated disorders of ovulation and the observed increase in GC production of AMH. Enhanced and premature LH action could also compensate, during mid-to-late follicular development, for the aforementioned initial defect of AMH production by primary and transitional follicles, in anovulatory women with PCOS (26) .
Intraovarian HA may be the main culprit for the follicular arrest. Indeed, it seems to lead to follicle excess, increasing the intraovarian AMH level, which then could exert an inhibiting effect on the selection process (11) . This notion is supported by our own observation that serum T levels were significantly and independently associated with circulating AMH (Table 4) . Nevertheless, ovulatory hyperandrogenic women with PCOS (group 3, classified as PCOS based on the revised criteria) had significantly lower AMH levels compared with anovulatory women with PCOS (groups 1 and 2, "classical" PCOS), whereas no difference was observed between groups 3 and 4, despite the presence of HA in the former (Fig. 1, Tables 2 and  3 ). Moreover, in multiple regression analysis, several other significant determinants were identified (Table 4) . Therefore, we postulate that AMH levels reflect a dynamic interaction between LH secretion and influence, androgens, and endogenous disorders of follicular maturation. It should be noted that circulating T might not accurately reflect intraovarian androgen concentration and action.
IR has been proposed as a "second hit" that nonspecifically contributes to PCOS-associated follicular arrest (5, 6, 11) . In the present study, the well-known (2, 14, 21) association between IR and obesity was confirmed; however, no independent significant association with PCOS was found, although a trend for higher HOMA-IR values in women with PCOS, especially its "severe" form, was observed (Tables 2 and 3 ). It should be noted, however, that these negative results may well have been limited by the wide spread of fasting indexes of IR values, which in small samples have been shown to be relatively inaccurate, compared with the "golden standard," i.e., the euglycemic hyperinsulinemic clamp (3). Nevertheless, no correlation between AMH and indexes of IR was observed whatsoever, and we presume that a direct relationship between the two is quite unlikely.
In conclusion, AMH levels reflect the severity of PCOS and are significantly increased in its "classical" phenotypic forms, based on the 1990 criteria, as opposed to its recently introduced subtypes. Moreover, AMH levels are negatively affected by increased adiposity in both women with the syndrome and normal control subjects. Opposite to previous suggestions, increased AMH levels in women with PCOS do not seem to be merely the result of increased small follicle number per se or increased androgen levels alone, since in the present study LH levels emerged as the most important independent determinant of AMH. It should be emphasized, though, that a causal relationship is at present difficult to establish and more properly designed studies are definitely needed.
